首页|HPV16 E6-295T/G和E6-350T/G变异位点影响IFNκ、MHC-Ⅰ、STAT1和IRF9蛋白质表达的研究

HPV16 E6-295T/G和E6-350T/G变异位点影响IFNκ、MHC-Ⅰ、STAT1和IRF9蛋白质表达的研究

扫码查看
目的 探讨 HPV16(Human Papillomavirus Type 16)E6-295T/G 和 E6-350T/G 变异位点对 IFNκ、MHC-Ⅰ、STAT1 和 IRF9 蛋白质表达的影响.方法 在宫颈癌细胞 C33A(HPV 阴性)中分别转染真核表达载体 295G/350G-GV230、295T/350G-GV230 和 295T/350T-GV230 作为实验组,以 NC-GV230 作为对照组.通过免疫组织化学法、Western blot方法检测 HPV16 E6 295T/G、350T/G不同变异位点对 IFNκ、MHC-Ⅰ、STAT1 和 IRF9 蛋白质表达的影响.通过 IBM SPSS Statistics 26 软件对实验结果进行统计学分析,P<0.05 为差异具有统计学意义,免疫组织化学法定量采用 image J软件进行阳性细胞计数.结果 Western blot 结果显示,免疫分子干扰素 κ(Interferon Kappa,IFNκ)的表达,HPV16 E6-295G/350G变异组较HPV16 E6-295T/350T原型组和HPV16 E6-295T/350G组降低(P<0.01,P<0.05).HPV16 E6-295G/350G 变异组的免疫分子主要组织相容性复合体 Ⅰ 类(Major Histocompatibility Complex Class I,MHC-I)的表达显著低于 HPV16 E6-295T/350T 原型组和 HPV16 E6-295T/350G 组(P<0.05).HPV16 E6-295G/350G变异组的信号转导子和转录激活子 1(Signal Transducer and Activator of Transcription 1,STAT1)表达显著低于 HPV16 E6-295T/350T 原型组和 HPV16 E6-295T/350G 组(P<0.05,P<0.01).变异组HPV16 E6-295G/350G与 HPV16 E6-295T/350T原型组和 HPV16 E6-295T/350G 变异组相比,干扰素调节因子 9(Interferon Regulatory Factor 9,IRF9)表达显著降低(P<0.05,P<0.01).结论 HPV16 病毒 E6 蛋白质可以降低IFNκ、MHC-Ⅰ、STAT1 和 IRF9 的蛋白质表达水平,E6 基因 T295G/T350G变异降低这些分子的表达作用最强.
Study on the influence of HPV16 E6-295T/G and E6-350T/G variation sites on the protein expression of IFNκ、MHC-Ⅰ、STAT1 and IRF9
Objective To explore the effect of variation sites E6-295T/G and E6-350T/G on the protein expression of IFNκ、MHC-Ⅰ、STAT1 and IRF9.Methods Cervical cancer cells C33A were transfected with eukaryotic expression vectors 295G/350G-GV230,295T/350G-GV230,295T/350T-GV230 as the experimental group and NC-GV230 as the control group.Immunohistochemistry and Western blot methods were used to detect the effects of HPV16 E6 295T/G and 350T/G variation sites on IFNκ、MHC-Ⅰ、STAT1 and IRF9.IBM SPSS Statistics 26 software was used for statistical analysis of the experimental results.P<0.05 was considered statistically significant.Immunohistochemical method was used to quantitatively count positive cells by image J software.Results The results of Western blot showed that the expression of IFNκ was decreased in the HPV16 E6-295G/350G variant group compared with the HPV16 E6-295T/350T prototype group and HPV16 E6-295T/350G(P<0.05,P<0.01).The expression of MHC-I in the HPV16 E6-295G/350G variants was significantly lower than that of HPV16 E6-295T/350T prototype group and HPV16 E6-295T/350G(P<0.05).The expression of STAT1 was significantly lower in HPV16 E6-295G/350G variant group than in HPV16 E6-295T/350T pro-totype group and HPV16 E6-295T/350G(P<0.01,P<0.05).IRF9 in HPV16 E6-295G/350G was significantly decreased than that of HPV16 E6-295T/350T prototype group and HPV16 E6-295T/350G(P<0.05,P<0.01).Conclusion HPV16 E6 protein can re-duce the expression of IFNκ,MHC-Ⅰ,STAT1 and IRF9,and E6 gene 295G/350G variation has the strongest effect on reducing the expression of these molecules.

cervical cancerHPV16E6 genegene variationprotein expression

李杨杨、辛慧珍、郭柄轩、王慧娟、宋树言、李洪涛、李冬妹、潘泽民

展开 >

石河子大学医学院生物化学教研室/新疆地方与民族高发病教育部重点实验室,新疆 石河子 832002

新疆医科大学基础医学院生物学教研室,新疆 乌鲁木齐 830017

石河子大学医学院人体解剖学与组织胚胎学教研室,新疆 石河子 832002

宫颈癌 HPV16 E6基因 基因变异 蛋白质表达

国家自然科学基金国家自然科学基金新疆生产建设兵团国际科技合作项目

82060518U15031252019BC007

2024

石河子大学学报(自然科学版)
石河子大学

石河子大学学报(自然科学版)

CSTPCD北大核心
影响因子:0.662
ISSN:1007-7383
年,卷(期):2024.42(2)
  • 20